Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer

By sjmartinez • April 30, 2024

Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May;13(9):e7212. doi: 10.1002/cam4.7212. PMID: 38686626; PMCID: PMC11058674.

Tags: APG‐157, Digestive Diseases, Head and neck cancer, Hematology/Oncology, immune checkpoint inhibitors, microbiome, Publications, tumor microenvironment, Veterans Administration

Tertiary Care Center Trends in Colonic Stent Placement over the Past Decade

Juakiem WY, Singh K, Ofosu A, Ramai D, Persaud A, Tabibian JH, Rodrigues-Pinto E, Girotra M, Barakat MT. Tertiary Care Center Trends in Colonic Stent[...]

Pancreas and biliary ablation devices

American Society for Gastrointestinal Endoscopy Technology Committee; Das KK, Chen D, Akshintala VS, Chen YI, Girotra M, Han S, Kahn A, Mishra G, Muthusamy VR,[...]

JPEN Journal Club 88. Determining the hypothesis of a study

Koretz RL. JPEN Journal Club 88. Determining the hypothesis of a study. JPEN J Parenter Enteral Nutr. 2024 Oct 10. doi: 10.1002/jpen.2696. Epub ahead of[...]